MoCRA Compliance Articles
Analysis and updates on mocra compliance matters from Anthony Girand, Esq.
Visit the MoCRA Compliance Attorney PageBeyond the Lab: Building a Defensible Safety Substantiation File
MoCRA doesn't dictate specific tests—it demands a scientifically defensible safety record. Here's how indie brands build one that actually holds up.
Read MoreManaging Your Biennial MoCRA Facility Registration Renewal: A Step-by-Step Guide
A practical, step-by-step walkthrough for founders navigating the Cosmetics Direct portal to verify and complete their mandatory MoCRA biennial facility renewal.
Read MoreBeyond Registration: 10 Essential MoCRA Compliance Pillars for Indie Brands
MoCRA's small business exemption covers only registration and listing. Indie founders remain fully liable for safety substantiation, adverse event reporting, and labeling.
Read MoreDecoding the FDA’s Finalized Mandatory Cosmetic Recall Guidance
FDA's October 2026 final guidance turns MoCRA's mandatory recall authority into operational reality—here's how responsible persons should prepare now.
Read MoreBuilding Your Safety Substantiation File: A Practical Guide for Indie Brands
A practical, budget-conscious roadmap for indie cosmetic founders to compile MoCRA-compliant safety substantiation files without costly clinical trials.
Read MoreDebunking FDA Compliance Certificates: What E-commerce Platforms Actually Need
FDA doesn't issue 'compliance certificates' for cosmetics—here's what MoCRA actually requires and how to respond to platform demands without faking paperwork.
Read MoreThe Small Business Trap: MoCRA Exemptions You Cannot Afford to Ignore
Small cosmetic brands may dodge MoCRA registration and GMP rules, but safety substantiation and adverse event reporting apply regardless of size.
Read MorePreparing for FDA Mandatory Recalls: A New MoCRA Enforcement Reality
FDA's October 2026 final guidance on MoCRA mandatory recall authority signals tighter timelines and less tolerance for delay—here's how to prepare.
Read MoreAvoiding the Drug Trap: Marketing Claims and MoCRA Compliance
One careless phrase in your marketing copy can legally transform your cosmetic into an unapproved drug. Here's how founders can avoid the trap.
Read MoreBuilding a Compliant Adverse Event Intake System for Indie Brands
A practical, founder-focused roadmap for building an adverse event intake system that meets MoCRA's strict 15-business-day FDA reporting deadline.
Read MoreMastering Fragrance Allergen Labeling: Preparing for Upcoming MoCRA Disclosure Mandates
FDA's forthcoming fragrance allergen disclosure rule under MoCRA will reshape cosmetic labeling—here's how founders can prepare before the mandate takes effect.
Read MoreFDA’s 2026 Draft Guidance on Mandatory Cosmetic Recall Authority
FDA's 2026 draft guidance signals a new era of mandatory cosmetic recalls under MoCRA—here's what Responsible Persons must do to prepare now.
Read MoreClarifying FDA Registration Status: Why Listing Numbers Are Not Compliance Certificates
FDA registration numbers under MoCRA confirm administrative compliance—not product safety or regulatory approval. Misrepresenting this distinction invites serious enforcement exposure.
Read MoreLeveraging the FAERS Dashboard for Proactive Cosmetic Safety Risk Mitigation
MoCRA has made cosmetic adverse event data public—companies that treat the dashboard as business intelligence, not paperwork, gain a decisive risk management advantage.
Read MoreLeveraging the FAERS Public Dashboard for Proactive Cosmetic Safety Monitoring
MoCRA's new reporting mandates and FDA's public adverse event dashboards demand proactive monitoring—companies that wait for enforcement letters have already fallen behind.
Read MoreShaping Future Cosmetic GMPs: Engaging in FDA’s New Rulemaking Process
FDA's forthcoming cosmetic GMP rules will reshape manufacturing compliance for years—stakeholders who stay silent during this rulemaking window risk losing their voice entirely.
Read MoreNavigating PFAS Disclosure: Analyzing FDA’s 2026 Cosmetic Safety Report Findings
FDA's 2026 PFAS cosmetic safety report raises the bar for MoCRA safety substantiation and signals a new wave of product liability exposure for brand owners.
Read MoreAddressing PFAS Liability: Navigating Emerging MoCRA Safety Substantiation Standards
FDA findings on PFAS in cosmetics are reshaping MoCRA compliance expectations, exposing gaps in safety substantiation files and heightening litigation risk.
Read MoreManaging E-commerce Platform Demands for Non-Existent FDA Compliance Certificates
E-commerce platforms demand FDA compliance certificates for cosmetics that the agency simply does not issue—creating a costly compliance gap under MoCRA.
Read MoreU.S. Cosmetics Regulatory Brief: What MoCRA Requires Now
FDA has confirmed it issues no MoCRA registration certificates, even as facility renewals, annual listing reviews, and Washington's formaldehyde-releaser ban arrive on individualized deadlines.
Read MoreManaging Asbestos Liability in Talc Cosmetics Following FDA’s Rule Withdrawal
FDA's withdrawal of its MoCRA talc-testing rule creates a compliance vacuum—cosmetic brands should adopt dual-microscopy testing now, not wait until 2026.
Read MoreNavigating the 2026 Biennial Cosmetic Facility Registration Renewal Cycle
As FDA enhances Cosmetics Direct with new status tracking, cosmetic facilities must proactively manage the 2026 biennial renewal cycle to avoid compliance gaps.
Read MoreMoCRA Contract Manufacturing Agreements: Managing Responsible Person and Supply Chain Liabilities
MoCRA has transformed cosmetics supply agreements into regulatory risk instruments—here's how brands and contract manufacturers should reallocate liability.
Read MoreMoCRA Litigation Risk: Defending Against FDA FAERS Public Dashboard Scrutiny
FDA's public FAERS cosmetic dashboard is reshaping MoCRA compliance into a litigation-readiness function—here's how Responsible Persons can get ahead of the risk.
Read MoreDecoding FDA’s New Safety Substantiation Burden Estimates for 2026 Compliance
FDA's updated burden-hour estimates for MoCRA safety substantiation reveal a demanding new documentation standard—one companies must address well before 2026.
Read MorePreparing for FDA Fragrance Allergen Labeling: A Proactive Compliance Strategy
FDA's fragrance allergen rule is coming—companies that audit formulations against EU standards now will avoid costly, last-minute reformulations later.
Read MorePreparing for FDA Mandatory Cosmetic Recalls: A Strategic Compliance Framework
MoCRA's new mandatory recall authority ends the FDA's reliance on voluntary compliance—companies must now build recall readiness directly into their regulatory strategy.
Read MoreManaging the 2026 Biennial MoCRA Facility Registration Renewal Cycle
As the first MoCRA biennial renewal approaches, companies must audit Cosmetics Direct data now to avoid registration inaccuracies and suspension risk.
Read MoreNavigating the 2026 Biennial MoCRA Facility Registration Renewal Cycle
As the first MoCRA biennial renewal window opens in 2026, cosmetic manufacturers must audit facility registration data now to avoid enforcement exposure.
Read MoreDefending MoCRA Preemption: Analyzing 2026 Court Rulings on State Safety Standards
As federal courts confront a wave of 2026 MoCRA preemption rulings, the line between permissible state disclosure laws and preempted safety mandates is rapidly taking shape.
Read MoreMoCRA Records Access: Managing Risks During FDA Remote Regulatory Assessments
FDA's expanded MoCRA authority to demand records during remote audits creates real enforcement risk. We outline the legal strategies cosmetic brands need now.
Read MoreMoCRA: Understanding the New Facility Registration Requirements
The Modernization of Cosmetics Regulation Act requires every cosmetic facility to register with FDA and renew every two years. Here is what brands, contract manufacturers, and importers need to know.
Read MoreCosmetic Labeling Under MoCRA: Fragrance Allergens, PFAS, and What's Coming
MoCRA updates cosmetic labeling rules and sets the stage for future requirements on fragrance allergen disclosure and PFAS. Brands must prepare for a new labeling landscape.
Read MoreMoCRA Product Listing Guide
An overview of MoCRA's cosmetic product listing requirement, including what information must be submitted to the FDA and how to keep listings current.
Read MoreMoCRA in 2026 and Startup Law Essentials: What Every Cosmetics Brand and Early-Stage Company Must Know
The Modernization of Cosmetics Regulation Act is reshaping how cosmetics reach the market — and the legal exposure that comes with noncompliance is growing fast. At the same time, startup founders face legal pitfalls that can cripple a young company before it ever reaches scale. This article addresses both.
Read MoreMoCRA and Adverse Event Reporting: What Cosmetic Brands Must Do
MoCRA mandates reporting serious adverse events to FDA within 15 business days and retaining records for six years. Understanding these obligations is essential for any responsible person.
Read MoreMoCRA Facility Registration Guide
What cosmetic manufacturers and processors need to know about MoCRA facility registration requirements, deadlines, and how to stay compliant with the FDA.
Read MoreMoCRA for Small Businesses and Importers: Key Compliance Considerations
MoCRA's reach extends to small cosmetic businesses and foreign importers. Understanding who is covered, what exemptions apply, and how to structure compliance is critical for these companies.
Read MoreMoCRA Labeling, Fragrance Allergens, and PFAS Issues
A look at MoCRA's cosmetic labeling requirements, the new fragrance allergen disclosure rules, and emerging PFAS concerns facing cosmetic companies.
Read MoreMoCRA Facility Registration Deadlines: What Cosmetic Manufacturers Must Do Now
MoCRA facility registration and product listing requirements remain a top compliance priority for cosmetic manufacturers in 2026.
Read MoreCosmetic Product Labeling Under MoCRA: Avoiding Common Compliance Pitfalls
MoCRA introduced new labeling obligations for cosmetic products, including fragrance allergen disclosure. Here's how to avoid common mistakes.
Read MoreAdverse Event Reporting Under MoCRA: Building a Compliant System
MoCRA's adverse event reporting requirements demand a formal internal process. Here's how cosmetic companies can build one that holds up.
Read MoreCosmetic Safety Substantiation and GMP: What MoCRA Requires
MoCRA requires responsible persons to maintain adequate safety substantiation for every cosmetic product. FDA is also finalizing Good Manufacturing Practice regulations. Here is how to prepare.
Read More